Cencora — Feb 5, 2025 release

Healthcare Solutions segment operating income growth to be in the range of 14.5 to 16.5 percent, from the previous range of 5 to 6.5 percent; ◦ International Healthcare Solutions segment as reported operating income growth to be flat, from the previous range of 5 to 6.5 percent; ▪ On a constant currency basis, International Healthcare Solutions segment operating income growth to be approximately 5 percent; • Net interest expense to be in the range of $290 million to $310 million, from the previous range of $150 million to $170 million; and • Weighted average diluted shares outstanding is expected to be under 196 million, from the previous expectation of approximately 196 million. For additional details regarding updated guidance expectations on a constant currency basis, please refer to our slide presentation for investors. Dividend Declaration     The Company’s Board of Directors declared a quarterly cash dividend of $0.55 per common share, payable March 3, 2025, to stockholders of record at the close of business on February 14, 2025. Conference Call & Slide Presentation The Company will host a conference call to discuss its operating results at 8:30 a.m. ET on February 5, 2025. A slide presentation for investors has also been posted on the Company’s website at investor.cencora.com. Participating in the conference call will be: • Robert P. Mauch, President & Chief Executive Officer • James F. Cleary, Executive Vice President & Chief Financial Officer The dial-in number for the live call will be (833) 470-1428. From outside the United States and Canada, dial +1 (404) 975-4839. The access code for the call will be 427679. The live call will also be webcast via the Company’s website at investor.cencora.com. Users are encouraged to log on to the webcast approximately 10 minutes in advance of the sch